Paper359019
A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a diuretic with uricosuric properties) in hypertension.
Gillies AH and 1 other. Br J Clin Pharmacol, 1978. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. A double-blind comparison of the effects of hydrochlorothiazide and tienylic acid (a diuretic with uricosuric properties) in hypertension. Papers, record 359019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/359019
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics25
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diuretics | Major topic |
| Glycolates | Major topic |
| Hydrochlorothiazide | Major topic |
| Hypertension | Major topic |
| Phenoxyacetates | Major topic |
| Thiophenes | Major topic |
| Adult | |
| Aged | |
| Blood Pressure | |
| Blood Urea Nitrogen | |
| Body Weight | |
| Carbon Dioxide | |
| Chlorides | |
| Clinical Trials as Topic | |
| Creatinine | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Liver Function Tests | |
| Male | |
| Middle Aged | |
| Phosphates | |
| Potassium | |
| Sodium | |
| Uric Acid |
Source PubMed
References4
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 796642 | Optimal dose of a thiazide diuretic. | Med J Aust | 1976 | https://conductscience.org/library/papers/796642 | PubMed |
| 2 | 4725465 | A comparison of chlorothiazide, chlorthalidone and cyclopenthiazide in the treatment of hypertension. | Med J Aust | 1973 | https://conductscience.org/library/papers/4725465 | PubMed |
| 3 | 5158836 | The long-term treatment of hypertension with thiazide diuretics. | Postgrad Med J | 1971 | https://conductscience.org/library/papers/5158836 | PubMed |
| 4 | 5859556 | Correlations among hyperuricemia, hypercholesterolemia, coronary disease and hypertension. | Arthritis Rheum | 1965 | https://conductscience.org/library/papers/5859556 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 7261949 | The risks of asymptomatic hyperuricaemia and the use of uricosuric diuretics. | Drugs | 1981 | https://conductscience.org/library/papers/7261949 | PubMed |
| 7049708 | Ticrynafen and hydrochlorothiazide. A comparison in hypertensive patients with renal impairment. | Eur J Clin Pharmacol | 1982 | https://conductscience.org/library/papers/7049708 | PubMed |
| 7004473 | Effect of tienilic acid and amiloride in healthy volunteers and in hypertensives with normal renal function. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/7004473 | PubMed |
| 6662184 | Long term treatment with tienilic acid or thiazides: comparison of antihypertensive and metabolic effects. | Eur J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6662184 | PubMed |
| 6344896 | Multicentre controlled trial of tienilic acid in hyperuricaemic, hypertensive subjects, with intensive monitoring of liver function. | Br J Clin Pharmacol | 1983 | https://conductscience.org/library/papers/6344896 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/359019
GET https://conductscience.org/api/papers/v1/359019/authors